Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. MDxHealth SA
  6. Summary
    MDXH   BE0003844611

MDXHEALTH SA

(MDXH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Bruxelles
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
0.912(c) 0.89(c) 0.912(c) 0.934(c) 0.932 Last
112 620 186 405 147 499 154 770 9 105 Volume
+6.29% -2.41% +2.47% +2.41% -0.21% Change
More quotes
Estimated financial data (e)
Sales 2021 20,3 M 22,9 M 22,9 M
Net income 2021 -24,7 M -27,8 M -27,8 M
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Sales 2022 26,3 M 29,7 M 29,7 M
Net income 2022 -25,8 M -29,1 M -29,1 M
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 146 M 165 M 165 M
Capi. / Sales 2021 7,17x
Capi. / Sales 2022 5,54x
Nbr of Employees 177
Free-Float 86,4%
More Financials
Company
MDxHealth SA is a Belgium-based multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The CompanyÔÇÖs tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to... 
More about the company
All news about MDXHEALTH SA
11/29MDxHealth Shares Rise After Analysts Start Coverage
MT
11/29Oppenheimer Initiates Coverage on MDxHealth With Outperform Rating, $18 Price Target
MT
11/29BTIG Starts MDxHealth SA at Buy With $15 Price Target
MT
11/29Piper Sandler Starts MDxHealth SA at Overweight With $15 Price Target
MT
11/22MDxHealth Shareholder Transparency Declarations
AQ
11/15MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States
GL
11/08MDxHealth Wraps Up Nasdaq Capital Market IPO
MT
11/08MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States
AQ
11/04MDXHEALTH SA(NASDAQCM : MDXH) added to NASDAQ Composite Index
CI
11/04MDxHealth Prices ADSs Ahead Of Nasdaq Capital Market Listing
MT
11/04MDxHealth Announces Pricing of Initial Public Offering of ADSs in the United States
AQ
10/28MDxHealth Announces Launch of Proposed Initial Public Offering of ADSs in the United St..
AQ
10/27Board Report in relation to the capital increase of 8 November 2021 (ENG)
PU
10/21ANALYST RECOMMENDATIONS : Ford, Hilton, IBM, Johnson & Johnson, Netflix...
10/21MDXHEALTH : Provides Q3-2021 Business Update
AQ
More news
News in other languages on MDXHEALTH SA
12/02Argen-x en Ackermans helpen Bel20 licht in het groen
11/29Les actions de MDxHealth augmentent après le début de la couverture par les analystes.
11/29Breed gedragen herstel in Brussel
11/29Brussel overwegend in het groen
11/22Déclarations de Transparence d'Actionnaires de MDxHealth
More news
Analyst Recommendations on MDXHEALTH SA
More recommendations
Chart MDXHEALTH SA
Duration : Period :
MDxHealth SA Technical Analysis Chart | MDXH | BE0003844611 | MarketScreener
Technical analysis trends MDXHEALTH SA
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 0,93 €
Average target price 1,20 €
Spread / Average Target 28,5%
Managers and Directors
Michael K. McGarrity Chief Executive Officer & Executive Director
Ron Kalfus Chief Financial Officer
Koen Hoffman Chairman
Joseph Sollee Chief Compliance Officer, EVP & General Counsel
Lieve Verplancke Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
MDXHEALTH SA4.94%165
MODERNA, INC.188.59%122 239
LONZA GROUP AG25.98%57 878
IQVIA HOLDINGS INC.46.64%50 192
SEAGEN INC.-9.40%29 014
CELLTRION, INC.-40.67%24 745